{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:07:17Z","timestamp":1763968037432,"version":"3.44.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ygyno.2011.02.019","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T16:53:26Z","timestamp":1299516806000},"page":"537-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia"],"prefix":"10.1016","volume":"121","author":[{"given":"Christoph","family":"Grimm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Watrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Baum\u00fchlner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Natter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zeillinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepp","family":"Leodolter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Reinthaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Hefler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.02.019_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","article-title":"Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia","volume":"85","author":"Schiffman","year":"1993","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0020","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/dji186","article-title":"Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0025","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/cncr.20142","article-title":"Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma","volume":"100","author":"Ricote","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/08830189809043005","article-title":"Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist","volume":"16","author":"Dinarello","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0035","first-page":"2429","article-title":"Interleukin-1 beta enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures","volume":"83","author":"Sauer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/S1064744902000200","article-title":"Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study","volume":"10","author":"Behbakht","year":"2002","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0045","first-page":"51","article-title":"Role of cytokines in the development of immunologic and homeostatic disorders in advanced dysplasia and carcinoma of the uterine cervix","volume":"49","author":"Belokrinitskaia","year":"2003","journal-title":"Vopr. Onkol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/cyto.2001.0909","article-title":"Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia","volume":"14","author":"Tjiong","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","article-title":"The two faces of IL-6 on Th1\/Th2 differentiation","volume":"39","author":"Diehl","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<244::AID-IJC15>3.0.CO;2-N","article-title":"Regulation of spontaneous and TNF\/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines","volume":"82","author":"Asschert","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0065","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1099\/0022-1317-82-10-2335","article-title":"Soluble interleukin-6 receptor activates the human papillomavirus type 18 long control region in SW756 cervical carcinoma cells in a STAT3-dependent manner","volume":"82","author":"Smola-Hess","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0070","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4049\/jimmunol.165.4.1939","article-title":"Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production","volume":"165","author":"Hess","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","article-title":"The balance between IL-1 and IL-1Ra in disease","volume":"13","author":"Arend","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.bjc.6600655","article-title":"Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer","volume":"87","author":"Salgado","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0085","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/bbrc.2000.3241","article-title":"Cancer cell-derived interleukin 1 alpha contributes to autocrine and paracrine induction of prometastatic genes in breast cancer","volume":"275","author":"Nozaki","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0095","first-page":"1812","article-title":"IL (Interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas","volume":"7","author":"Wolf","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0100","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-05-0188","article-title":"A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth","volume":"65","author":"Su","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/ijgc-00009577-200305000-00012","article-title":"A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer","volume":"13","author":"Srivani","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0090-8258(02)00154-3","article-title":"Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma","volume":"89","author":"Fujiwaki","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0115","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2362.1992.tb01480.x","article-title":"TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro","volume":"22","author":"Pociot","year":"1992","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0125","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/hmg\/1.6.450","article-title":"Single base polymorphism at \u2212511 in the human interleukin-1 beta gene (IL1 beta)","volume":"1","author":"di Giovine","year":"1992","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0130","first-page":"251","article-title":"A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals","volume":"11","author":"Hulkkonen","year":"2000","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.1995.tb05549.x","article-title":"Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism","volume":"99","author":"Danis","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0140","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.ATV.20.11.2394","article-title":"Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis","volume":"20","author":"Dewberry","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0888-7543(88)90152-8","article-title":"The human \u201cinterferon-beta 2\/hepatocyte stimulating factor\/interleukin-6\u201d gene: DNA polymorphism studies and localization to chromosome 7p21","volume":"3","author":"Bowcock","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0150","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0008-6363(01)00534-X","article-title":"Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein","volume":"53","author":"Vickers","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0160","first-page":"6243","article-title":"Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma","volume":"54","author":"Tartour","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1471-0528.2007.01655.x","article-title":"Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer","volume":"115","author":"Singh","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0170","first-page":"1099","article-title":"Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer","volume":"23","author":"Mustea","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijgo.2007.10.014","article-title":"Interleukin 1 beta gene polymorphism and risk of cervical cancer","volume":"101","author":"Sobti","year":"2008","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0180","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/ijgc-00009577-200605000-00049","article-title":"Interleukin-6 polymorphisms and the risk of cervical cancer","volume":"16","author":"Nogueira de Souza","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/172460080902400102","article-title":"Association of interleukin-6\u2013174G>C promoter polymorphism with risk of cervical cancer","volume":"24","author":"Gangwar","year":"2009","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0190","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ygyno.2003.11.039","article-title":"A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis","volume":"92","author":"Grimm","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jsgi.2005.08.002","article-title":"A common interleukin-6 promoter polymorphism in patients with vulvar cancer","volume":"12","author":"Grimm","year":"2005","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0200","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1080\/10428190701615892","article-title":"Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma","volume":"48","author":"Abazis-Stamboulieh","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1373\/clinchem.2005.058537","article-title":"Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia","volume":"52","author":"Endler","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2370.2003.00361.x","article-title":"Genotyping for cytokine polymorphisms: allele frequencies in the Italian population","volume":"30","author":"Uboldi de Capei","year":"2003","journal-title":"Eur. J. Immunogenet"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007890-200102150-00022","article-title":"Donor cytokine genotype influences the development of acute rejection after renal transplantation","volume":"71","author":"Marshall","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0220","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1177\/00220345000790110801","article-title":"Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease","volume":"79","author":"Shirodaria","year":"2000","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor\u2013host interactions","volume":"25","author":"Apte","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0230","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ijc.24529","article-title":"Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population\u2014a candidate gene approach","volume":"125","author":"Castro","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0235","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","article-title":"Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia","volume":"87","author":"Ho","year":"1995","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ygyno.2011.02.019_bb0240","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1001\/jama.285.23.2995","article-title":"Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females","volume":"285","author":"Moscicki","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.02.019_bb0245","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1158\/1055-9965.EPI-04-0918","article-title":"Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology","volume":"14","author":"McIntyre-Seltman","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:32:52Z","timestamp":1758771172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0090825811001399"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.019","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}